The rates of survival for a person with lung cancer depend on various important factors. 1) The first factor that affects the survival rate for a person with lung cancer is the KIND of lung cancer. Lung cancer is divided into two general kinds or categories.
Archive for November, 2009
Lung Cancer Survival
November 8th, 2009 by RemwesMedical
Lung Cancer Stages
November 8th, 2009 by RemwesMedical
The stage at which a lung cancer is initially found is a very important factor in determining the possible treatments available for the lung cancer as well as for determining the outlook or prognosis for the person with lung cancer. Lung Cancers are divided into two general categories.
Posted in Lung Cancer 
Tags: lung cancer stages, lung cancer staging, stages of lung cancer 
No Comments »Lung Cancer Prognosis
November 8th, 2009 by RemwesMedical
The prognosis for lung cancer is dependent on a number of factors. First and foremost is if the cancer is a Small Cell Lung Cancer or a Non Small Cell Lung Cancer. The prognosis is very different depending on which type of lung cancer is found. Small Cell lung cancer is more aggressive than Non Small Cell […]
Lung Cancer Treatment
November 8th, 2009 by RemwesMedical
The treatment of lung cancer depends on various factors, but one main factor is the type of lung cancer. Lung cancers can be divided into two basic types. One type is called a Small Cell Lung Cancer and the other type is called a Non-Small Cell Lung Cancer. Small Cell lung cancer is the more […]
Avastin
November 6th, 2009 by RemwesMedical
When an army moves forward, it needs to make sure that its SUPPLY LINE is able to keep up with it. The supply line is critical to an army as that is what will provide the army with food rations and ammunition for the soldiers and gasoline for the tanks. Cancers do a similar function.
Tarceva
November 6th, 2009 by RemwesMedical
Tarceva is a drug commonly used to treat several types of non-small cell lung cancer. Often Tarceva is used used together with gemcitabine to treat pancreatic cancer. Tarceva is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.